Here are the DEF 14A proxy statements from Passage Bio, Inc. (PASG) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PASG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PASG filings page.
Passage Bio, Inc. is holding its 2026 Annual Meeting of Stockholders as a virtual-only event on May 19, 2026 at 9:00 a.m. Eastern Time. Holders of 3,207,810 shares of common stock as of March 26, 2026 may vote.
Stockholders will vote on electing two Class III directors, ratifying KPMG LLP as independent auditor for 2026, approving on a non-binding advisory basis the compensation of named executive officers, and choosing how often to hold future advisory pay votes. The board recommends voting for both nominees, for KPMG, for executive pay, and for an annual say-on-pay vote.
The proxy also details governance practices, committee structures, director and executive pay, stock ownership of major holders and management, and change-in-control and severance protections for senior executives.